Novo Nordisk buys Akero Therapeutics in the US
ReutersOct 9, 2025 10:07 AM
STOCKHOLM, Oct 9 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
The Accounting behind Oracle’s AI Ambitions
TradingKey - On the 7th of October, Oracle stock fell 5% after a report shared by The Information giving more insights into the company’s profitability in their own cloud business. The day after, the stock rebounded, but the questions remain.TradingKey
2 hours ago
BOE Seen Poised for Further Rate Cuts.Sterling Seen Extending Slide Against Dollar
TradingKey - UK Economy Shows Persistent Weakness as Construction Slump Deepens.The UK economy remains under pressure, with S&P Global’s latest purchasing managers’ index (PMI) released on the 6th showing that construction activity contracted for a ninth consecutive month in September.TradingKey
6 hours ago
FOMC October Meeting Minutes: How Should Investors Respond?
In the context of the U.S. government shutdown and a period of limited economic data, the Federal Reserve’s release of its latest monetary policy meeting minutes and officials’ statements on 8 October will be particularly significant.TradingKey
Tue, Oct 7
Is the UK Economy Headed for Collapse? Will Assets Face a "Triple Slump" in Stocks, Exchange Rates, and Bonds?
Many investors and analysts assert that the UK economy is on the brink of collapse, with its assets facing a "triple slump" across stocks, foreign exchange, and bonds.TradingKey
Mon, Oct 6
U.S. Government Shutdown Commentary: Is a Stock Market Crash Imminent? Will Gold Prices Continue to Surge?
TradingKey - On 1 October 2025, the U.S. federal government officially entered a shutdown, impacting various asset classes. This article analyses two key markets most affected—U.S. equities and gold—to help investors identify potential opportunities.TradingKey
Wed, Oct 1
